KRAS and colorectal cancer: Similarly, in colorectal cancer, two studies evaluating the effect of necrosis on KRAS mutation detection found that a high content of necrosis, including in those specimens with up to 70% necrosis, had no effect on the results of either single-gene PCR or amplicon-based NGS assays [48,49].